This company has been marked as potentially delisted and may not be actively trading. Medicines (MDCO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MDCO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered TrimaranSeptember 16, 2025 | financialpost.comFTYK Medicines Announces Board Composition and Committee RolesSeptember 15, 2025 | tipranks.comTYK Medicines Faces Temporary Non-Compliance Following Director ResignationSeptember 15, 2025 | tipranks.comBeOne Medicines Completes Employee Share Purchase PlanSeptember 12, 2025 | tipranks.comBeOne Medicines (ONC) Reports Positive Phase 1/2 Results for Sonrotoclax in MCLSeptember 12, 2025 | insidermonkey.comAnalysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer DrugSeptember 11, 2025 | benzinga.comRevolution Medicines: Shares Soar On Pancreatic Cancer Study Win - I'm SoldSeptember 11, 2025 | seekingalpha.comPromising Position of Revolution Medicines’ Zoldonrasib Justifies Buy RatingSeptember 11, 2025 | tipranks.comPromising Potential of Daraxonrasib in Pancreatic Cancer Boosts Buy Rating for Revolution MedicinesSeptember 11, 2025 | tipranks.comRevolution Medicines rises on daraxonrasib data that supports phase 3 programSeptember 10, 2025 | seekingalpha.comRevolution Medicines Reports Promising Phase 1 Study ResultsSeptember 10, 2025 | tipranks.comRevolution Medicines Reports Promising Long-term Data for Daraxonrasib in Metastatic Pancreatic Cancer and Announces Phase 3 Trial PlansSeptember 10, 2025 | quiverquant.comQAntares Vision Group Partners with Gambia’s MCA for Pharmaceutical TraceabilitySeptember 10, 2025 | tipranks.comTrump Weighs Crackdown on Medicines From ChinaSeptember 10, 2025 | nytimes.comWHO Updates List Of Essential Medicines To Include Key Cancer, Diabetes Treatments September 8, 2025 | rttnews.comFDA Tightens Grip On Safe Weight Loss Drugs, WHO Adds Them To Essential Medicines ListSeptember 7, 2025 | benzinga.comPraxis Precision Medicines Signs New Sales AgreementSeptember 5, 2025 | tipranks.comPraxis Precision Medicines to Present at Upcoming Investor Conferences in September 2025September 4, 2025 | quiverquant.comQBeOne Medicines Ltd. Launches New Employee Share Purchase Plan OfferingSeptember 4, 2025 | tipranks.comBeOne Medicines Ltd. Announces Grant of Restricted Share Units to EmployeesSeptember 4, 2025 | tipranks.comBiophytis Secures EMA Approval for Phase 2 Obesity TrialSeptember 3, 2025 | tipranks.comTYK Medicines Announces Board Composition and RolesAugust 31, 2025 | tipranks.comTYK Medicines Enhances Treasury Operations with Strategic InvestmentsAugust 31, 2025 | tipranks.comTYK Medicines Reports Reduced Losses in H1 2025August 31, 2025 | tipranks.comBeOne Medicines Ltd. (ONC) Unveils Promising Breast Cancer Therapies at ASCO 2025August 29, 2025 | finance.yahoo.comBeOne Medicines Stock Gains Momentum With Early-Stage Trial Success For Pretreated Lymphoma PatientsAugust 29, 2025 | benzinga.comEverest Medicines Announces 2025 Interim ResultsAugust 28, 2025 | tipranks.comBeOne Medicines Ltd. (ONC) Unveils Promising Breast Cancer Therapies at ASCO 2025August 28, 2025 | insidermonkey.comKingworld Medicines Reports Decline in H1 2025 Financial PerformanceAugust 27, 2025 | tipranks.comEuropean Commission Approves TEVIMBRA® as Neoadjuvant/Adjuvant NSCLC Treatment Ahead of Late-Breaking Data Presentation at WCLC 2025August 27, 2025 | mms.businesswire.comTYK Medicines, Inc. Explores Distribution Partnership for TY-9591August 26, 2025 | tipranks.comBeOne Medicines: Brukinsa's Leadership And Royalty Sale Signal A Stronger FutureAugust 26, 2025 | seekingalpha.comPraxis Precision Medicines to Present Recent Epilepsy Study Results at International Epilepsy Congress 2025August 25, 2025 | quiverquant.comQBeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 MillionAugust 25, 2025 | gurufocus.comBeOne Medicines Ltd (ONC) Announces $950 Million Royalty Rights Sale to Royalty Pharma | ONC ...August 25, 2025 | gurufocus.comBeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 MillionAugust 25, 2025 | mms.businesswire.comBeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million | ONC ...August 25, 2025 | gurufocus.comBeOne Medicines Secures $885 Million Royalty Deal with Royalty PharmaAugust 25, 2025 | tipranks.comBeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 MillionAugust 25, 2025 | financialpost.comFPraxis Precision Medicines Inc (PRAX) Under Investigation for Potential Securities Law ...August 23, 2025 | gurufocus.comWhere U.S. Medicines Are Made and How Trump’s Tariffs Could Affect ThemAugust 23, 2025 | nytimes.comTYK Medicines Reports Non-compliance Incident by DirectorAugust 21, 2025 | tipranks.comKingworld Medicines Group Ltd. Projects Significant Profit Decline for H1 2025August 21, 2025 | tipranks.comEuropean Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA® for All Approved IndicationsAugust 21, 2025 | financialpost.comF3D Medicines Partners with CATUG Biotechnology to Enhance mRNA Therapy DevelopmentAugust 20, 2025 | tipranks.comTYK Medicines, Inc Announces Upcoming Board Meeting for Interim ResultsAugust 20, 2025 | tipranks.comPiper Sandler Initiates Coverage on Revolution Medicines (RVMD) | RVMD Stock NewsAugust 19, 2025 | gurufocus.comRein Therapeutics Gains Approval for Phase 2 TrialAugust 19, 2025 | tipranks.comRevolution Medicines' SWOT analysis: promising cancer drug stock faces pivotal yearAugust 18, 2025 | investing.comWellington Management Group LLP Reduces Stake in Revolution Medicines IncAugust 17, 2025 | gurufocus.com Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDCO Media Mentions By Week MDCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDCO News Sentiment▼0.000.76▲Average Medical News Sentiment MDCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDCO Articles This Week▼37▲MDCO Articles Average Week Get the Latest News and Ratings for MDCO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Medicines and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies RPRX News Today JAZZ News Today CORT News Today PRGO News Today SUPN News Today PCRX News Today NKTR News Today OMER News Today ASMB News Today CPIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDCO) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThis Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top...Crypto 101 Media | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Medicines Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDCO Stock Alerts